Neil E Reiner

Title: Neil E Reiner: Innovator in Protein Analysis and Infectious Disease Treatment

Introduction

Neil E Reiner is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the fields of protein analysis and infectious disease treatment. With a total of 3 patents, his work has advanced the understanding and methodologies in these critical areas.

Latest Patents

One of Neil's latest patents focuses on the diagnosis and treatment of infectious diseases through indel-differentiated proteins. This innovative compound is capable of specifically binding to pathogen EF-1α but not host EF-1α. The compound binds to any part of an amino acid sequence having at least 70% sequence identity to amino acids 240-230 of SEQ ID NO:22. Another notable patent involves methods and apparatus for protein sequence analysis. This patent discloses apparatus, methods, media, signals, and data structures for protein sequence analysis. The method includes identifying, from among a first group of aligned protein sequences, a second group of at least one of the aligned sequences having at least one insertion or deletion ('indel') relative to the first protein sequence satisfying a predefined condition. The apparatus may include a processor circuit configured to carry out the method.

Career Highlights

Neil E Reiner is affiliated with the University of British Columbia, where he continues to contribute to research and innovation in his field. His work has garnered attention for its potential applications in healthcare and biotechnology.

Collaborations

Neil has collaborated with notable colleagues, including Artem Tcherkassov and Devki Nandan, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Neil E Reiner's innovative work in protein analysis and infectious disease treatment exemplifies the importance of research and development in advancing medical science. His contributions continue to influence the field and inspire future innovations.